Antisense modulation of IL7R splicing to control sIL7R expression in human CD4 + T cells is a research paper published in RNA (2022). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: R41-AI141323
NIH
Grant: R41-AI149920
NIAID NIH HHS
Grant: R43 AI143319
NIAID NIH HHS
Grant: R41 AI141323
NIAID NIH HHS
Grant: R41 AI149920
National Institutes of Health
Grant: 1R41AI141323-01A1
Development of a novel accurate therapy for Multiple Sclerosis
National Institutes of Health
Grant: 1R41AI149920-01
Determination of optimal antisense oligonucleotide chemistry for efficient and safe splicing modulation in T cells
National Institutes of Health
Grant: 1R43AI143319-01
Novel accurate therapy for Multiple Sclerosis: Optimization of antisense oligonucleotides delivery and functionality in primary T cells
University of Texas Medical Branch
a Technology Commercialization Plan grant from the University of Texas Medical Branch
FWCI
0.30
Citation Percentile
0.5%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals